Back to Blog
May 8, 2022
Figure 1 - nferX Signals app query for "Adenovirus AND Receptor" across the core corpus (PubMed, Preprints, Clinical Trials, SEC filings, Patents etc) shows CXADR gene as strongest candidate for viral receptor from published biomedical literature.
Figure 2B - nferX Proteomics app shows that CXADR protein is also expressed at lower levels of enrichment in the respiratory tract (e.g. saliva, lungs) as well as the gastrointestinal system (e.g. colon, rectum)
Figure 2C - nferX Proteomics app details show 9 different mass spectrometry studies as all displaying normal and diseased liver tissues with enriched CXADR protein levels.
Figure 2D - nferX Proteomics app helps dive into 1 of the 9 individual studies with Mass Spec data, showing CXADR significantly expressed in 223 of 248 liver samples from both non-tumor (healthy) liver as well as hepatocellular carcinoma liver samples.
Figure 2E - nferX Proteomics app shows fetal brain and heart tissues express the CXADR protein from mass spectrometry data suggesting pediatric population may also express CXADR protein in these tissues.
Figure 2F - nferX Proteomics app shows fetal liver, heart and ovary tissues express the CXADR protein from mass spectrometry data suggesting pediatric population may also express CXADR protein in these tissues.
Figure 3. nferX proteomics app has an immunohistochemistry (IHC) panel that shows that liver tissue stains moderately with a CXADR antibody (Source: Imaging data from Human Protein Atlas - HPA).
Figure 4a - nferX Single Cell app shows that Hepatic stem cells and Cholangiocytes have one of the most significant expression levels for the CXADR gene.
Figure 4b - nferX Single Cell app enables comprehensive profiling of over 3 million single cell RNA-seq (scRNAseq) human samples and provides distribution of 310K+ cell samples with non-zero expression of CXADR gene. This result shows that both the respiratory tract (nasal cavity, lungs) as well as gastrointestinal system (large intestine, small intestine) have cell types expressing the CXADR gene.
Figure 5a - nferX RNA Explorer app enables comparison of cohorts across studies for CXADR gene expression. Here Group A has White ethnicity samples (n = 6497) from 118 studies, being compared with Group B with 7 studies of African American/Black and Hispanic/Latino individual's samples (n=124).
Figure 5b - nferX RNA Explorer app shows individuals in Group B (African American/Black or Latino/Hispanic ethnicity) having modestly more expression of CXADR gene than Group A (White ethnicity) with Cohen's D value of 1.06 (effect size).
Featuring key corporate highlights and an overview of nference’s technology